6.19
price up icon2.65%   0.16
after-market After Hours: 6.40 0.21 +3.39%
loading

Diamedica Therapeutics Inc Stock (DMAC) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Research and Development
0.03%
3.676
3.677 3.272 2.543 3.618
Operating Income/Loss
1.83%
-5.741
-5.848 -5.157 -4.741 -5.521
Income/Loss From Continuing Operations Before Tax
0.10%
-5.144
-5.139 -4.464 -4.47 -5.265
Income Tax Expense/Benefit
68.18%
0.007
0.022 0.007 0.007 0.007
Income/Loss From Continuing Operations After Tax
0.19%
-5.151
-5.161 -4.471 -4.477 -5.272
Net Income/Loss
0.19%
-5.151
-5.161 -4.471 -4.477 -5.272
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,991%
37.96
1.8154 37.95 27.31 26.45
Basic Earnings Per Share
0.00%
-0.14
-0.14 -0.12 -0.16 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):